Analyst upgrades: WCG, BCON, TUES, WST and VVC
Posted Nov 5th 2007 10:50AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, MasterCard Inc'A' (MA)
.gif)
MOST NOTEWORTHY: WellCare Health, Beacon Power, Tuesday Morning, West Pharmaceutical Services and Vectren were today's noteworthy upgrades:
- Jefferies upgraded shares of WellCare Health (NYSE: WCG) to Buy from Hold, as they believe the investigation could most likely result in fines as opposed to the loss of contracts with the company's government customers.
- Merriman raised its rating on Beacon Power (NASDAQ: BCON) to Buy from Neutral, as they believe the company is well-positioned for significant penetration of the growing frequency regulation markets.
- Piper upgraded shares of Tuesday Morning (NASDAQ: TUES) to Outperform from Market Perform as they believe the company's sales and margins trends are stabilizing.
- UBS upgraded West Pharmaceutical Services (NYSE: WST) to Buy from Neutral on valuation.
- Citigroup upgraded shares of Vectren (NYSE: VVC) to Buy from Hold, as they believe 2008 will be an inflection point with the share issuance and rate relief aiding earnings.
OTHER UPGRADES:
- Goldman added Roche (OTC: RHHBY) to its Conviction Buy List.
- Zumiez (NASDAQ: ZUMZ) was upgraded to Buy from Hold at McAdams, Wright.
- Thomas Weisel upgraded MasterCard (NYSE: MA) to Market Weight from Underweight.
- UBS upgraded Arcelor Mittal (NYSE: MT) to Buy from Hold.
Tags: analyst, arcelor mittal, ArcelorMittal, bcon, beacon power, BeaconPower, ma, mastercard, mt, rhhby, roche, tues, tuesday morning, TuesdayMorning, upgrade, vectren, vvc, wcg, wellcare, west pharma, WestPharma, wst, zumiez, zumz
Entrepreneur's Journal: Want to get a piece of the Buffett/Goldman honeypot?
The week in preview: No turkey earnings from Tyson, Hormel, Cracker Barrel ...
Comfort Zone Investing: Intel is saying something ... can you hear it?
